Dentin bond strength of an experimental adhesive system containing calcium chloride, synthetic peptides derived from dentin matrix protein 1 (pA and pB), and hydroxyapatite for direct pulp capping and as a bonding agent.
Summary of "Dentin bond strength of an experimental adhesive system containing calcium chloride, synthetic peptides derived from dentin matrix protein 1 (pA and pB), and hydroxyapatite for direct pulp capping and as a bonding agent."
The purpose of this study was to evaluate the microtensile bond strength (muTBS) of an experimental adhesive system containing calcium chloride (CaCl(2)), synthetic peptides derived from dentin matrix protein 1 (DMP1: pA and pB), and hydroxyapatite experimentally developed for direct pulp capping to human dentin. Clearfil SE Bond/Primer (SEP) and Bond (SEB) were used for each experimental group as the matrix agents. Experimental self-etching primers included: primer-I, SEP containing 10 wt% CaCl(2), and primer-II, SEP containing a 10 wt% compound of pA and pB. The experimental bonding agent was a mixture of SEB and 10 wt% hydroxyapatite. Specimens were divided into five experimental groups, including the control, according to the mode of primer application. Primer-I was primarily applied, followed by primer-II for group 1, primer-I as the primary and SEP as the secondary for group 2, SEP as the primary and primer-II as the secondary for group 3, and SEP was applied twice for group 4, and SEP was applied once for the control. Clearfil SE Bond adhesive system was used as the control. Flat dentin surfaces of human molars were assigned to bonding tests. After each experimental primer was applied to the dentin surface, each experimental bonding agent was applied and photopolymerized, and then resin composite paste (Clearfil Flow FX and Clearfil AP-X) was placed and photopolymerized. The specimens were subjected to muTBS testing. The data were compared using analysis of variance (ANOVA) and post-hoc Bonferroni/Dunn tests. Results showed that the minimum mean value of muTBS was 15.4 MPa for group 1, while the maximum mean value of muTBS was 52.7 MPa for the control. There were significant differences among the experimental groups, except for group 4 and the control. The experimental primers containing CaCl(2) or DMP1 negatively affected the muTBS value of the experimental adhesive system to dentin.
Department of Operative Dentistry, The Nippon Dental University School of Life Dentistry at Niigata, 1-8 Hamaura-cho, Chuo-ku, Niigata, 951-8580, Japan, email@example.com.
This article was published in the following journal.
Name: Odontology / the Society of the Nippon Dental University
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20652788
- DOI: http://dx.doi.org/10.1007/s10266-010-0125-4
To evaluate the effect of saliva contamination on the shear bond strength of a new two-step self-etch adhesive (P90 system adhesive) to dentin and to determine the effect of contaminant removing treat...
to evaluate the influence of preheating the bonding agent (Scotchbond Multipurpose Adhesive/3M ESPE) and the light-activated resin cement (RelyX Venner/3M ESPE) on dentin microtensile bond strength.
The lack of long-term bond stability between resin cements and dentin may compromise the success of indirect restorations.
A few studies have investigated the effect of the activation mode of adhesive systems on bond strength of fiber posts to root canal dentin. This study investigated the push-out bond strengths of a gla...
The erbium:yttrium-aluminum-garnet (Er:YAG) laser may be effective the bond strength of adhesive systems on dentine surfaces, the chemical composition and aggressiveness of adhesive systems in clinica...
The purpose of this study is to compare the clinical performance of three dental adhesive systems used to bond Class V cavity fillings in adult teeth.
The Veterans Health Administration (VHA) has stated the need for a brief screening instrument that can assist with the triage of the enormous number of returning OEF/OIF veterans with conc...
The primary objective of this study was to compare the adhesive quality of the current Mylan estradiol placebo transdermal system, with that of an alternate second generation Mylan estradi...
The purpose of this study is to compare two treatments for adhesive capsulitis.
Extensive experimental and observational data suggest that intake of calcium and of vitamin D exert protective effects on colorectal neoplasia. Building on their previous work, the invest...
Medical and Biotech [MESH] Definitions
Cements that act through infiltration and polymerization within the dentinal matrix and are used for dental restoration. They can be adhesive resins themselves, adhesion-promoting monomers, or polymerization initiators that act in concert with other agents to form a dentin-bonding system.
Adherent debris produced when cutting the enamel or dentin in cavity preparation. It is about 1 micron thick and its composition reflects the underlying dentin, although different quantities and qualities of smear layer can be produced by the various instrumentation techniques. Its function is presumed to be protective, as it lowers dentin permeability. However, it masks the underlying dentin and interferes with attempts to bond dental material to the dentin.
An autologous or commercial tissue adhesive containing FIBRINOGEN and THROMBIN. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, FACTOR VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as APROTININ. Mixing of the two components promotes BLOOD CLOTTING and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, HEMOSTASIS, and WOUND HEALING.
Adhesive tape with the mechanical strength to resist stretching. It is applied to the skin to support, stabilize, and restrict movement to aid healing and/or prevent injuries of MUSCULOSKELETAL SYSTEM.
Experimental animal models for human AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM. They include GUILLAIN-BARRE SYNDROME (see NEURITIS, AUTOIMMUNE, EXPERIMENTAL); MYASTHENIA GRAVIS (see MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL); and MULTIPLE SCLEROSIS (see ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL).